HIV

High-End HIV Drug Stribild To Set Gilead Sciences Apart

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Seeking Alpha

Stribild: It's FDA-Approved, but Will It Sell?

Stribild: It's FDA-Approved, but Will It Sell?

Motley Fool

Gilead pricing for Stribild makes sense, says Deutsche Bank

Gilead pricing for Stribild makes sense, says Deutsche Bank

The Fly on the Wall

Gilead’s 4-In-1 Stribild HIV Pill Wins U.S. FDA Approval

Gilead’s 4-In-1 Stribild HIV Pill Wins U.S. FDA Approval

Bloomberg

PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision

PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision

Yahoo/Reuters

Submitted by moderatorj on Mon, 08/20/2012 - 23:04

RPT-US health panel likely to make HIV tests routine

RPT-US health panel likely to make HIV tests routine

Reuters

Democrats Caution Gilead Over Quad Pricing

Democrats Caution Gilead Over Quad Pricing

Pharmalot

Bionor Pharma Rises As HIV Drug Study Gets Approval: Oslo Mover

Bionor Pharma Rises As HIV Drug Study Gets Approval: Oslo Mover

Bloomberg

Mylan subsidiary starts operations in India

Mylan subsidiary starts operations in India

Yahoo/AP

Gilead inks low-cost HIV drug deal with generics makers

Gilead inks low-cost HIV drug deal with generics makers

Fierce Pharma